Table 1 Characteristics of the patients with NAFLD.
Variables | All patients | Males | Females |
|---|---|---|---|
(n = 52) | (n = 27) | (n = 25) | |
Age (years) | 55 ± 13.8 | 48 ± 14.6 | 63 ± 7.5 |
Weight (kg) | 68 ± 12.0 | 75 ± 11.0 | 59 ± 6.2 |
BMI (kg/m2) | 26 ± 2.8 | 27 ± 3.2 | 26 ± 2.2 |
Blood platelet count (×104/μL) | 22 ± 5.5 | 22 ± 5.3 | 22 ± 4.7 |
AST (IU/L) | 26 ± 9.1 | 28 ± 9.5 | 23 ± 8.1 |
ALT (IU/L) | 30 ± 18.2 | 37 ± 20.0 | 22 ± 12.2 |
ALP (IU/L) | 243 ± 69.8 | 206 ± 63.2 | 284 ± 52.1 |
γ-GTP (IU/L) | 57 ± 74.4 | 80 ± 95.8 | 31 ± 18.6 |
Fasting plasma glucose (mg/dL) | 105 ± 14 | 106 ± 16 | 104 ± 11 |
HOMA-IR | 2.1 ± 1.5 | 1.8 ± 1.1 | 2.4 ± 1.9 |
Total cholesterol (mg/dL) | 219 ± 48 | 227 ± 46 | 218 ± 25 |
High density lipoprotein (mg/dL) | 57 ± 14 | 54 ± 14 | 62 ± 12 |
Triglyceride (mg/dL) | 145 ± 100 | 165 ± 128 | 124 ± 58 |
L/S ratio | 1.12 ± 0.21 | 1.07 ± 0.26 | 1.17 ± 0.15 |
